🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine if cladribine tablets are a safe a...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00213135
Treatments Being Tested
To study the impact of cladribine on peripheral and intrathecal B-cell, pla...
Status
Completed
Location
Barts Health NHS Trust
Start Date
2019-07-01
Trial ID
NCT06415864
MS is a chronic inflammatory and degenerative disease of the central nervou...
Status
Active Not Recruiting
Location
Queens University Belfast (Belfast Health and Social Care Trust)
Start Date
2021-06-25
Trial ID
NCT04695080
Treatments Being Tested
The main aim and overall objective of the study is to assess whether rituxi...
Status
Completed
Location
Department of Neurology - Drammen, Vestre Viken HF
Start Date
2019-10-16
Trial ID
NCT04121403
Treatments Being Tested
Prolonged anti CD20 therapy for the treatment of active multiple sclerosis ...
Status
Unknown
Location
Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano
Start Date
2020-12-17
Trial ID
NCT04640818
Treatments Being Tested
The goal of this study was to evaluate the safety, tolerability and effecti...
Status
Completed
Location
Research Site
Start Date
2006-11-30
Trial ID
NCT00436826
Treatments Being Tested
The purpose of this study is to better understand the mechanism of action (...
Status
Completed
Location
Washington University School of Medicine
Start Date
2019-10-28
Trial ID
NCT03963375
Treatments Being Tested
The purpose of this study is to explore the concept that biomarker sensitiv...
Status
Unknown
Location
Multiple Sclerosis Center of Northeastern New York, P.C.
Start Date
2020-09-16
Trial ID
NCT04550455
Treatments Being Tested
To evaluate the effectiveness, patient-reported outcomes (PROs) and safety ...
Status
Completed
Location
University of Arkansas for Medical Sciences
Start Date
2019-05-21
Trial ID
NCT03933215
Treatments Being Tested
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested